Endoscopic Nd:YAG laser therapy for active esophageal variceal bleeding. A randomized controlled study

Area of Science:

• Gastroenterology
• Endoscopic therapy
• Hepatology

Background:

• Esophageal variceal bleeding is a serious complication of portal hypertension.
• Endoscopic therapies are crucial for managing acute variceal bleeding.
• Neodymium:yttrium aluminum garnet (Nd:YAG) laser therapy has been explored for hemostasis.

Purpose of the Study:

• To evaluate the efficacy and safety of endoscopic Nd:YAG laser therapy for active esophageal variceal bleeding.
• To compare Nd:YAG laser therapy with sham endoscopy and standard medical care.

Main Methods:

• A randomized controlled double-blind study was conducted.
• Ten patients received endoscopic Nd:YAG laser therapy.
• Ten patients received sham endoscopy and standard medical therapy.

Main Results:

• Initial hemostasis was achieved in 70% of laser-treated patients versus 0% in controls (p < 0.002).
• Rebleeding occurred in 40% of initially controlled laser patients, resulting in lasting hemostasis in 30%.
• Blood transfusion requirements and mortality rates were similar between groups.

Conclusions:

• Endoscopic Nd:YAG laser therapy provides initial hemostasis for esophageal variceal bleeding but has a high rebleeding rate.
• Nd:YAG laser therapy did not significantly improve outcomes compared to standard care in this study.
• Further research is needed to optimize endoscopic treatment strategies for variceal bleeding.